You are on page 1of 2

Federal Register / Vol. 70, No.

56 / Thursday, March 24, 2005 / Notices 15109

research opportunities with the DEPARTMENT OF HEALTH AND Contact Person: Keith A. Mintzer, PhD,
inventors. HUMAN SERVICES Scientific Review Administrator, Review
Branch, Division of Extramural Affairs,
Cannula for Pressure Mediated Drug National Institutes of Health National Heart, Lung, and Blood Institute,
Delivery National Institutes of Health, 6701 Rockledge
Stephen Wiener, Robert Hoyt, John Clinical Center; Amended Notice of Drive, Room 7186, MSC 7924, Bethesda, MD
20892, 301–435–0280.
Deleonardis, Randal Clevenger, Robert Meeting
Lutz, Brian Safer (NHLBI) (Catalogue of Federal Domestic Assistance
PCT Application No. PCT/US99/11277 Notice is hereby given of a change in Program Nos. 93.233, National Center for
the meeting of the NIH Advisory Board Sleep Disorders Research; 93.837, Heart and
filed 21 May 1999, which published Vascular Diseases Research; 93.838, Lung
as WO 99/59666 on 25 Nov 1999 for Clinical Research, March 28, 2005,
10 a.m. to March 28, 2005, 2 p.m., Diseases Research; 93.839, Blood Diseases
(DHHS Reference No. E–196–1998/2– and Resources Research, National Institutes
PCT–01); U.S., Australian, Japanese, National Institutes of Health, Building
of Health, HHS)
and European rights pending 10, 10 Center Drive, Medical Board
Room 4–2551, Bethesda, MD, 20892 Dated: March 17, 2005.
Licensing Contact: Michael LaVerne Y. Stringfield,
which was published in the Federal
Shmilovich; 301/435–5019;
Register on March 11, 2005, FR 70 Director, Office of Federal Advisory
shmilovm@mail.nih.gov. Committee Policy.
12223.
Available for licensing are methods
The open session will occur from 10 [FR Doc. 05–5870 Filed 3–23–05; 8:45 am]
and devices for selective delivery of
a.m.–1 p.m. The closed session will BILLING CODE 4140–01–M
therapeutic substances to specific
begin approximately at 1 p.m. and run
histologic or microanatomic areas of
until 2 p.m. The meeting will be held
organs (introduction of the therapeutic
in the Clinical Center, Bldg. 10, Rm. 4– DEPARTMENT OF HEALTH AND
substance into a hollow organ space
2551, CRC Medical Board Room. The HUMAN SERVICES
(such as an hepatobiliary duct or the
meeting is partially closed to the public.
gallbladder lumen) at a controlled National Institutes of Health
pressure, volume or rate allows the Dated: March 17, 2005.
substance to reach a predetermined LaVerne Y. Stringfield, National Institute of Diabetes and
cellular layer (such as the epithelium or Director, Office of Federal Advisory Digestive and Kidney Diseases; Notice
sub-epithelial space). The volume or Committee Policy. of Closed Meetings
flow rate of the substance can be [FR Doc. 05–5872 Filed 3–23–05; 8:45 am]
controlled so that the intralumenal BILLING CODE 4140–01–M Pursuant to section 10(d) of the
pressure reaches a predetermined Federal Advisory Committee Act, as
threshold level beyond which amended (5 U.S.C. Appendix 2), notice
subsequent subepithehal delivery of the DEPARTMENT OF HEALTH AND is hereby given of the following
substance occurs. Alternatively, a lower HUMAN SERVICES meetings.
pressure is selected that does not exceed The meetings will be closed to the
the threshold level, so that delivery National Institutes of Health public in accordance with the
occurs substantially only to the provisions set forth in sections
epithelial layer. Such site-specific National Heart, Lung, and Blood
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
delivery of therapeutic agents permits Institute; Notice of Closed Meeting
as amended. The grant applications
localized delivery of substances (for Pursuant to section 10(d) of the and/or contract proposals and the
example to the interstitial tissue of an Federal Advisory Committee Act, as discussions could disclose confidential
organ) in concentrations that may amended (5 U.S.C. Appendix 2), notice trade secrets or commercial property
otherwise produce systemic toxicity. is hereby given of the following such as patentable material, and
Occlusion of venous or lymphatic meeting. personal information concerning
drainage from the organ can also help The meeting will be closed to the individuals associated with the grant
prevent systemic administration of public in accordance with the applications and/or contract proposals,
therapeutic substances, and increases provisions set forth in sections the disclosure of which would
selective delivery to superficial 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., constitute a clearly unwarranted
epithelial cellular layers. Delivery of as amended. The grant applications and invasion of personal privacy.
genetic vectors can also be better the discussions could disclose Name of Committee: National Institute of
targeted to cells where gene expression confidential trade secrets or commercial Diabetes and Digestive and Kidney Diseases
is desired. The access device comprises property such as patentable material, Special Emphasis Panel, Antidepressant
a cannula with a wall piercing tracar and personal information concerning Therapy for Functional Dyspepsia.
within the lumen. Two axially spaced individuals associated with the grant Date: April 4, 2005.
inflatable balloons engage the wall applications, the disclosure of which Time: 3 p.m. to 4:30 p.m.
securing the cannula and sealing the would constitute a clearly unwarranted Agenda: To review and evaluate grant
puncture site. A catheter equipped with applications.
invasion of personal privacy. Place: National Institutes of Health, Two
an occlusion balloon is guided through Name of Committee: National Heart, Lung, Democracy Plaza, 6707 Democracy
the cannula to the location where the and Blood Institute Special Emphasis Panel, Boulevard, Bethesda, MD 20892. (Telephone
therapeutic substance is to be delivered. Review of Research Projects (Cooperative Conference Call).
Dated: March 17, 2005. Agreements) (U01s). Contact Person: Lakshmanan Sankaran,
Steven M. Ferguson, Date: April 18, 2005. PhD, Scientific Review Adminstrator, Review
Time: 2 p.m. to 3:30 p.m. Branch, DEA, NIDDk, National Institutes of
Director, Division of Technology Development Agenda: To review and evaluate Health, Room 777, 6707 Democracy
and Transfer, Office of Technology Transfer, cooperative agreement applications. Boulevard, Bethesda, MD 20892–5452, (301)
National Institutes of Health. Place: National Institutes of Health, 6701 594–7799, Is38oz@nih.gov.
[FR Doc. 05–5875 Filed 3–23–05; 8:45 am] Rockledge Drive, Bethesda, MD 20892, This notice is being published less than 15
BILLING CODE 4140–01–P (Telephone Conference Call). days prior to the meeting due to the timing

VerDate jul<14>2003 15:04 Mar 23, 2005 Jkt 205001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\24MRN1.SGM 24MRN1
15110 Federal Register / Vol. 70, No. 56 / Thursday, March 24, 2005 / Notices

limitations imposed by the review and Dated: March 17, 2005. Date: April 19, 2005.
funding cycle. LaVerne Y. Stringfield, Time: 8 a.m. to 12 p.m.
Name of Committee: National Institute of Director, Office of Federal Advisory Agenda: To review and evaluate grant
Diabetes and Digestive and Kidney Diseases Committee Policy. applications.
Place: Hilton Alexandria Old Town, 1767
Special Emphasis Panel, Nuclear Receptors [FR Doc. 05–5862 Filed 3–23–05; 8:45 am] King Street, Alexandria, VA 22314.
Structure and Function. BILLING CODE 4140–01–M Contact Person: Richard Crosland, PhD,
Date: April 11, 2005. Scientific Review Administrator, Scientific
Time: 2 p.m. to 5 p.m. Review Branch, Division of Extramural
Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND Research NINDS/NIH/DHHS/ Neuroscience
applications. HUMAN SERVICES Center, 6001 Executive Blvd., Suite 3208,
Place: National Institutes of Health, Two MSC 9529, Bethesda, MD 20892–9529. 301–
Democracy Plaza, 6707 Democracy National Institutes of Health 594–0635. rc218u@nih.gov.
Boulevard, Bethesda, MD 20892. (Telephone Name of Committee: National Institute of
Conference Call). National Institute of Neurological Neurological Disorders and Stroke Special
Contact Person: Paul A. Rushing, PhD, Disorders and Stroke; Notice of Closed Emphasis Panel, Olfactory Receptors.
Scientific Review Administrator, Review Meetings Date: April 20, 2005.
Branch, DEA, NIDDK, National Institutes of Time: 12:30 p.m. to 2:30 p.m.
Health, Room 747, 6707 Democracy Pursuant to section 10(d) of the Agenda: To review and evaluate grant
Boulevard, Bethesda, MD 20892–5452, (301) Federal Advisory Committee Act, as applications.
594–8895, rushingp@extra.niddk.nih.gov. amended (5 U.S.C. Appendix 2), notice Place: National Institutes of Health,
This notice is being published less than 15 is hereby given of the following Neuroscience Center, 6001 Executive
days prior to the meeting due to the timing meetings. Boulevard, Rockville, MD 20852. (Telephone
limitations imposed by the review and The meetings will be closed to the Conference Call).
funding cycle. Contact Person: Richard D. Crosland, PhD,
public in accordance with the Scientific Review Administrator, Scientific
Name of Committee: National Institute of provisions set forth in sections Review Branch, Division of Extramural
Diabetes and Digestive and Kidney Diseases 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Research, NINDS/NIH/DHHS/Neuroscience
Special Emphasis Panel, Loan Repayment. as amended. The grant applications and Center, 6001 Executive Blvd., Suite 3208,
Date: April 13, 2005. the discussions could disclose MSC 9529, Bethesda, MD 20892–9529, (301)
Time: 1 p.m. to 3:30 p.m. confidential trade secrets or commercial 594–0635, rc218u@.nih.gov.
Agenda: To review and evaluate loan property such as patentable material, Name of Committee: National Institute of
repayment. Neurological Disorders and Stroke Special
and personal information concerning
Place: National Institutes of Health, Two Emphasis Panel, Ischemic Stroke Review.
Democracy Plaza, 6707 Democracy
individuals associated with the grant
Date: April 28, 2005.
Boulevard, Bethesda, MD 20892. (Telephone applications, the disclosure of which Time: 10:30 a.m. to 12 p.m.
Conference Call). would constitute a clearly unwarranted Agenda: To review and evaluate grant
Contact Person: D.G. Patel, PhD, Scientific invasion of personal privacy. applications.
Review Administrator, Review Branch, DEA, Name of Committee: National Institute of Place: National Institutes of Health,
NIDDK, National Institutes of Health, Room Neurological Disorders and Stroke Special Neuroscience Center, 6001 Executive
755, 6707 Democracy Boulevard, Bethesda, Emphasis Panel Fellowship Review. Boulevard, Rockville, MD 20852. (Telephone
MD 20892–5452, (301) 594–7682, Date: April 6, 2005. Conference Call).
pateldg@niddk.nih.gov. Time: 8 a.m. to 6 p.m. Contact Person: Richard D. Crosland, PhD,
This notice is being published less than 15 Agenda: To review and evaluate grant Scientific Review Administrator, Scientific
days prior to the meeting due to the timing applications. Review Branch, Division of Extramural
limitations imposed by the review and Place: Radisson Barcello, 2121 P Street, Research, NINDS/NIH/DHHS/Neuroscience
NW., Washington, DC 20037. Center, 6001 Executive Blvd., Suite 3208,
funding cycle.
Contact Person: Joann McConnell, PhD, MSC 9529, Bethesda, MD 20892–9529, (301)
Name of Committee: National Institute of Scientific Review Administrator, Scientific 594–0635. rc218u@.nih.gov.
Diabetes and Digestive and Kidney Diseases Review Branch, NIH/NINDS/Neuroscience (Catalogue of Federal Domestic Assistance
Special Emphasis Panel, Beta Cell Biology Center, 6001 Executive Blvd., Suite 3208, Program Nos. 93.853, Clinical Research
Consortium. MSC 9529, Bethesda, MD 20892–9529. (301) Related to Neurological Disorders; 93.854,
Date: April 14, 2005. 496–5324, mcconnej@ninds.nih.gov. Biological Basis Research in the
Time: 8:30 a.m. to 4 p.m. Name of Committee: National Institute of Neurosciences, National Institutes of Health,
Agenda: To review and evaluate grant Neurological Disorders and Stroke Special HHS)
applications. Emphasis Panel, Stroke Rehabilitation
Place: Bethesda Marriott Suites, 6711 Review. Dated: March 17, 2005.
Democracry Boulevard, Bethesda, MD 20817. Date: April 14, 2005. LaVerne Y. Stringfield,
Contact Person: Ned Feder, MD, Scientific Time: 10:30 a.m. to 12:30 p.m. Director, Office of Federal Advisory
Review Administrator, Review Branch, DEA, Agenda: To review and evaluate grant Committee Policy.
NIDDK, National Institutes of Health, Room applications. [FR Doc. 05–5863 Filed 3–23–05; 8:45 am]
778, 6707 Democracy Boulevard, Bethesda, Place: National Institutes of Health,
BILLING CODE 4140–01–M
MD 20892–5452, (301) 594–8890, Neuroscience Center, 6001 Executive
federn@extra.niddk.nih.gov. Boulevard, Rockville, MD 20852. (Telephone
This notice is being published less than 15 Conference Call.)
Contact Person: Richard Crosland, PhD, DEPARTMENT OF HEALTH AND
days prior to the meeting due to the timing
Scientific Review Administrator, Scientific HUMAN SERVICES
limitations imposed by the review and Review Branch, Division of Extramural
funding cycle. Research NINDS/NIH/DHHS/ Neuroscience National Institutes of Health
(Catalogue of Federal Domestic Assistance Center, 6001 Executive Blvd., Suite 3208,
Program Nos. 93.847, Diabetes, MSC 9529, Bethesda, MD 20892–9529, 301– National Institute of Diabetes and
Endocrinology and Metabolic Research; 594–0635, rc218u@nih.gov. Digestive and Kidney Diseases; Notice
93.848, Digestive Diseases and Nutrition Name of Committee: National Institute of of Closed Meetings
Research; 93.849, Kidney Diseases, Urology Neurological Disorders and Stroke Special
and Hematology Research, National Institutes Emphasis Panel, Howard University SNRP Pursuant to section 10(d) of the
of Health, HHS) Review. Federal Advisory Committee Act, as

VerDate jul<14>2003 15:04 Mar 23, 2005 Jkt 205001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\24MRN1.SGM 24MRN1